Page last updated: 2024-09-03

n,n-dimethylarginine and Cardiomyopathies, Primary

n,n-dimethylarginine has been researched along with Cardiomyopathies, Primary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderssohn, M; Böger, RH; Frey, N; Lüneburg, N; Lutz, M; Rosenberg, M; Schwedhelm, E; Zugck, C1
Benedetto, FA; Cutrupi, S; Malatino, L; Mallamaci, F; Pizzini, P; Tripepi, G; Zoccali, C1

Other Studies

2 other study(ies) available for n,n-dimethylarginine and Cardiomyopathies, Primary

ArticleYear
The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy.
    Journal of cardiac failure, 2012, Volume: 18, Issue:12

    Topics: Arginine; Biomarkers; Cardiomyopathies; Cardiomyopathy, Dilated; Chromatography, Liquid; Creatinine; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Natriuretic Peptide, Brain; Peptide Fragments; Severity of Illness Index; Tandem Mass Spectrometry

2012
Urotensin II and cardiomyopathy in end-stage renal disease.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:2

    Topics: Adult; Aged; Arginine; Cardiomyopathies; Cardiotonic Agents; Echocardiography; Female; Heart Atria; Humans; Kidney Failure, Chronic; Male; Medical Records; Middle Aged; Multivariate Analysis; Nitric Oxide; Sympathetic Nervous System; Urotensins; Ventricular Function, Left

2008